Abstract:Objective To develop and validate one optimal MR radiomics model for lymph node (LN) re-evaluation of locally advanced rectal cancer (LARC) after neoadjuvant chemoradiotheray (NCRT). Methods Four hundred and seven patients with clinicopathologically confirmed LARC in Beijing Cancer Hospital were included in this study from July 2010 to June 2015. All patients received NCRT before surgery,and underwent T2WI and DWI before and after NCRT.These patients were chronologically divided in the primary cohort(300 patients)and independent validation cohort(107 patients).The predicting model was trained and validated using postoperative pathological findings as truth values. By using radiomics method, we extracted the features of the tumor and the largest LN before and after neoadjuvant therapy, combined different features of the tumor and/or the largest LN before and/or after neoadjuvant therapy,and constructed 4 different prediction models,compared the performance of four predicting models.The optimal model with the highest accuracy was validated in the independent cohort. Decision curve analysis was conducted to determine the clinical usefulness of the radiomics nomograms by quantifying the net benefits at different threshold probabilities in the validation dataset. Results In the primary cohort, the radiomics signatures from 4 models provided an AUC of 0.637, 0.709, 0.753, 0.835, respectively in LN re-evaluation after chemoradiotheray. The diagnostic efficacy of model 4 was much better than that of 1, 2 and 3 model. In the validation cohort, the radiomics signatures provided an AUC of 0.795 for LN re-evaluation after chemoradiotheray. The sensitivity, specificity, positive predictive value, negative predictive value were 0.813, 0.693, 0.531, 0.897, respectively (95% CI: 0.694 to 0.896, 0.647 to 0.911, 0.582 to 0.786, 0.361 to 0.621, 0.792 to 0.952). While the probability of predicting N+ ranges from 17% to 80%, using the proposed radiomics model to predict N+ shows a greater advantage than either the scheme in which all patients were assumed to N+ or the scheme in which all patients are N-. Decision curve analysis demonstrated that the radiomics nomograms were clinically useful. Conclusion With a systematic analysis and comparison of both pre-and post-NCRT MRI data, we constructed an optimal individualized LN re-evaluation model based on MR radiomics, combing primary tumor and the largest LN features, compared with other models (only with pre/post tumor or pre/post largest LN features).

MRI for nodal restaging after neoadjuvant therapy in rectal cancer with histopathologic comparison

Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: a single center experience

Magnetic Resonance Imaging in Restaging Rectal Cancer after Neoadjuvant Chemoradiotherapy.

MRI for Restaging Locally Advanced Rectal Cancer: Detailed Analysis of Discrepancies with the Pathologic Reference Standard

Contrast-enhanced MRI for T Restaging of Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy and Radiation Therapy

Value of MRI Morphologic Features with Pt1-2 Rectal Cancer in Determining Lymph Node Metastasis

Locally advanced rectal cancer:an MRI radiomics study on lymph node re-evaluation after neoadjuvant chemoradiotherapy

Prediction of pathological response and lymph node metastasis after neoadjuvant therapy in rectal cancer through tumor and mesorectal MRI radiomic features

Preoperative T and N Restaging of Rectal Cancer After Neoadjuvant Chemoradiotherapy: An Accuracy Comparison Between MSCT and MRI

MRI Radiomics Signature to Predict Lymph Node Metastasis after Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer

Endosonography Elastography and Magnetic Resonance Imaging in the Restaging and Response Assessment of Rectal Cancer After Neoadjuvant Therapy

Value of High-resolution MRI in Detecting Lymph Node Calcifications in Patients with Rectal Cancer.

Development and validation of a radiomics model based on lymph-node regression grading after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Effects of MRI radiomics combined with clinical data in evaluating lymph node metastasis in mrT1-3a staging rectal cancer

Prediction of Pathological Nodal Stage of Locally Advanced Rectal Cancer by Collective Features of Multiple Lymph Nodes in Magnetic Resonance Images Before and after Neoadjuvant Chemoradiotherapy

The Current Status of Nodal Staging in Rectal Cancer

Magnetic resonance imaging-based lymph node radiomics for predicting the metastasis of evaluable lymph nodes in rectal cancer

Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study

[Assessment of Lymph Node Status in Rectal Cancer by Imaging].

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer